Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.

Autor: Bauer K; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Machherndl-Spandl S; Department of Internal Medicine I, Ordensklinikum, Linz, Austria.; Medical Faculty, Johannes Kepler University, Linz, Austria., Kazianka L; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Sadovnik I; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Gültekin S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Suessner S, Proell J; Medical Faculty, Johannes Kepler University, Linz, Austria.; Department of Molecular Biology, Transfusion Service of Upper Austria, Linz, Austria., Lauf J; Labor Europaplatz, Linz, Austria., Hoermann G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; MLL Munich Leukemia Laboratory, Munich, Germany., Eisenwort G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Häfner N; Department of Gynaecology and Obstetrics, Jena University Hospital, Jena, Germany., Födermayr-Mayrleitner M; Laboratory for Molecular and Genetic Diagnostics, Ordensklinikum, Linz, Austria., Schmolke AS; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., van der Kouwe E; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Platzbecker U; Division of Hematology, University of Dresden, Dresden, Germany.; Medical Clinic and Polyclinic I, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Lion T; Children´s Cancer Research Institute Vienna und Department of Pediatrics, Medical University of Vienna, Vienna, Austria., Weltermann A; Department of Internal Medicine I, Ordensklinikum, Linz, Austria., Zach O; Laboratory for Molecular and Genetic Diagnostics, Ordensklinikum, Linz, Austria., Webersinke G; Laboratory for Molecular and Genetic Diagnostics, Ordensklinikum, Linz, Austria., Germing U; Department of Hematology, Oncology and Clinical Immunology, Medical University of Düsseldorf, Düsseldorf, Germany., Gabriel C; Department of Molecular Biology, Transfusion Service of Upper Austria, Linz, Austria., Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Béné MC; Hematology Laboratory, CHU de Nantes, Nantes, France., Staber PB; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Bettelheim P; Labor Europaplatz, Linz, Austria.; Laboratory for Molecular and Genetic Diagnostics, Ordensklinikum, Linz, Austria., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria. peter.valent@meduniwien.ac.at.

Publikováno v: Leukemia [Leukemia] 2023 Nov; Vol. 37 (11), pp. 2250-2260. Date of Electronic Publication: 2023 Sep 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.

Autor: Machherndl-Spandl S; Department of Internal Medicine I with Hematology, Stem Cell Transplantation, Hemostasis and Medical Oncology, Ordensklinikum Elisabethinen Hospital, Linz, Austria., Jäger E; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Barna A; Blood Transfusion Service, Blood Transfusion Service for Upper Austria, Austrian Red Cross, Linz, Austria., Gurbisz M; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Marschon R; Laboratory for molecular and genetic diagnostics, Ordensklinikum Linz, Linz, Austria., Graf T; Department of Internal Medicine V with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria., Graf E; Department of Internal Medicine V with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria., Geissler C; Department of Laboratory Medicine, Hospital Hietzing, Vienna, Austria., Hoermann G; MLL Munich Leukemia Laboratory, Munich, Germany.; Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO), Medical University of Vienna, Vienna, Austria., Nösslinger T; Department of Internal Medicine III, Hanusch Hospital, Vienna, Austria., Pfeilstöcker M; Department of Internal Medicine III, Hanusch Hospital, Vienna, Austria., Bettelheim P; Department of Internal Medicine I with Hematology, Stem Cell Transplantation, Hemostasis and Medical Oncology, Ordensklinikum Elisabethinen Hospital, Linz, Austria., Zach O; Laboratory for molecular and genetic diagnostics, Ordensklinikum Linz, Linz, Austria., Weltermann A; Department of Internal Medicine I with Hematology, Stem Cell Transplantation, Hemostasis and Medical Oncology, Ordensklinikum Elisabethinen Hospital, Linz, Austria., Heibl S; Department of Internal Medicine IV, Hospital Wels-Grieskirchen, Wels, Austria., Thaler J; Department of Internal Medicine IV, Hospital Wels-Grieskirchen, Wels, Austria., Zebisch A; Division of Hematology, Medical University of Graz, Graz, Austria.; Otto-Loewi Research Centre for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Graz, Austria., Sill H; Division of Hematology, Medical University of Graz, Graz, Austria., Stauder R; Internal Medicine V with Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Webersinke G; Laboratory for molecular and genetic diagnostics, Ordensklinikum Linz, Linz, Austria., Kusec R; Internal Medicine V with Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.; School of Medicine, University Hospital Dubrava, University of Zagreb, Zagreb, Croatia., Ulsperger E; Department of Internal Medicine, Hospital Horn, Horn, Austria., Schneeweiss B; Department of Internal Medicine, Hospital Kirchdorf, Kirchdorf, Austria., Öhler L; Department of Internal Medicine/Oncology, St. Josef Hospital, Vienna, Austria., Germing U; Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany., Valent P; Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO), Medical University of Vienna, Vienna, Austria.; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Tüchler H; Department of Internal Medicine III, Hanusch Hospital, Vienna, Austria., Geissler K; Department of Internal Medicine V with Hematology, Oncology and Palliative Medicine, Hospital Hietzing, Vienna, Austria.; Sigmund Freud University, Vienna, Austria.

Publikováno v: European journal of haematology [Eur J Haematol] 2021 Aug; Vol. 107 (2), pp. 265-274. Date of Electronic Publication: 2021 Jun 01.